It's in our DNA - £7.5m funding round for Oxford Genetics
Published on
2 min read
Invesco Asset Management Limited (“Invesco”) and Mercia Technologies PLC has just completed a £7.5 million funding round in Oxford Genetics, a synthetic biology company with significant expertise in developing complex biological systems.